A Primer on COL4A1/COL4A2 -Related Cerebral Small Vessel Disease for Neurologists
- 10 November 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (9) , e218628
Abstract
COL4A1 and COL4A2 encode type IV collagen, a principal structural component of basement membranes, and pathogenic variants in these genes cause a multisystem small vessel vasculopathy with prominent cerebrovascular involvement. Despite increasing recognition with the expansion of genetic testing, COL4A1/2-related cerebral small vessel disease remains underrecognized in clinical practice, in part due to its striking phenotypic heterogeneity. Presentations span a broad clinical spectrum-from asymptomatic individuals or incidental imaging findings to recurrent ischemic events, intracerebral hemorrhage, and catastrophic perinatal brain injury-and may occur across the lifespan. In this narrative review, we provide a clinically oriented framework for recognizing and managing COL4A1/2-related cerebral small vessel disease. We integrate underlying molecular mechanisms of type IV collagen dysfunction with vascular pathophysiology, highlighting how impaired basement membrane integrity leads to a dual hemorrhagic-ischemic phenotype. We describe characteristic neuroimaging patterns, including microhemorrhages, white matter hyperintensities, lacunes, and dilated perivascular spaces, and emphasize their anatomic distribution and clinical relevance. Given the systemic nature of the disorder, we also review key extracerebral manifestations-including ocular, renal, and musculoskeletal features-that serve as important diagnostic "red flags." We outline practical considerations for clinical care, including indications for genetic testing, initial diagnostic evaluation, and longitudinal management strategies tailored to neurologists. Particular emphasis is placed on individualized decision-making around antithrombotic therapy, hemorrhage risk mitigation, and surveillance for complications such as intracranial aneurysms. Illustrative multigenerational cases are incorporated to demonstrate genotype-phenotype correlation, incomplete penetrance, and common diagnostic pitfalls. By providing a mechanism-informed and clinically actionable synthesis, this review aims to improve recognition, reduce misdiagnosis, and guide management of COL4A1/2-related cerebral small vessel disease.Keywords
This publication has 60 references indexed in Scilit:
- Phenotype and surgical management of drug‐resistant epilepsy in patients with COL4A1 and COL4A2 variantsEpilepsia Open, 2025
- Disruption of a miR‐29 binding site leading to COL4A1 upregulation causes pontine autosomal dominant microangiopathy with leukoencephalopathyAnnals of Neurology, 2016
- Next generation sequencing uncovers a missense mutation in COL4A1 as the cause of familial retinal arteriolar tortuosityGraefe's Archive for Clinical and Experimental Ophthalmology, 2014
- COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathyJournal of Neurology, 2014
- Phenotypic Spectrum of COL4A1 Mutations: Porencephaly to SchizencephalyAnnals of Neurology, 2012
- Ophthalmological Features Associated With COL4A1 MutationsArchives of Ophthalmology (1950), 2010
- COL4A1 mutation in Axenfeld–Rieger anomaly with leukoencephalopathy and strokeAnnals of Neurology, 2007
- Neonatal porencephaly and adult stroke related to mutations in collagen IV A1Annals of Neurology, 2006
- The genes for the alpha 1(IV) and alpha 2(IV) chains of human basement membrane collagen type IV are arranged head‐to‐head and separated by a bidirectional promoter of unique structure.The EMBO Journal, 1988
- Circulations of the cerebral hemispheresBritish Journal of Surgery, 1965